# Valneva Announces Successful Outcome of its Annual General Meeting - Valneva
Canonical URL: https://biopharmsignal.com/news/VLA/valneva-announces-successful-outcome-of-its-annual-general-meeting-valneva-577e38e0
Ticker: VLA
Company: Valneva
Source: Valneva
Published: 2026-06-25 15:45 EST
Original Source URL: https://valneva.com/media/press-releases/
## Summary

Lyon (France), June 25, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company (“the Company”), today announced that shareholders approved all resolutions recommended by the Board of Directors at the Company’s Annual General Meeting (AGM), held earlier today in Lyon, France. To access the full release, please click on the PDF below.

## Article Body
Skip to content

Lyon (France), June 25, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company (“the Company”), today announced that shareholders approved all resolutions recommended by the Board of Directors at the Company’s Annual General Meeting (AGM), held earlier today in Lyon, France.

To access the full release, please click on the PDF below.

Press release

We use cookies to improve the functionality and user experience of the website and to analyse the traffic. You can find detailed information in our Privacy Policy . ACCEPT REJECT CHANGE MY PREFERENCES
## Recent Company News
- 2026-06-25 15:45 EST — [Valneva Announces Successful Outcome of its Annual General Meeting - Valneva](https://biopharmsignal.com/news/VLA/valneva-announces-successful-outcome-of-its-annual-general-meeting-valneva-577e38e0) — Source: Valneva
- 2026-06-19 13:15 EST — [Valneva Press Releases | Latest Company News & Updates](https://biopharmsignal.com/news/VLA/valneva-press-releases-latest-company-news-updates-06632964) — Source: Valneva
- 2026-06-19 13:15 EST — [Valneva Press Releases | Latest Company News & Updates](https://biopharmsignal.com/news/VLA/valneva-press-releases-latest-company-news-updates-055eaaa3) — Source: Valneva
- 2026-06-04 12:13 EST — [Valneva Announces Availability of Documentation for its Annual General Meeting - Valneva](https://biopharmsignal.com/news/VLA/valneva-announces-availability-of-documentation-for-its-annual-general-meeting-v-51b0f491) — Source: Valneva
- 2026-05-28 15:48 EST — [Valneva to Participate at U.S. and European Investor Conferences in June - Valneva](https://biopharmsignal.com/news/VLA/valneva-to-participate-at-u-s-and-european-investor-conferences-in-june-valneva-8de339b9) — Source: Valneva
## Related News
- 2026-07-21 12:00 EST — MOR — [Novartis delivered sales growth in Q2 and further advanced the pipeline; Full-year guidance reaffirmed](https://biopharmsignal.com/news/MOR/novartis-delivered-sales-growth-in-q2-and-further-advanced-the-pipeline-full-yea-63a32b47)
- 2026-07-21 10:28 EST — GSK — [ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults alongside INSTI-powered long-acting injectable innovation at AIDS 2026](https://biopharmsignal.com/news/GSK/viiv-healthcare-to-present-phase-iiib-data-comparing-dovato-with-biktarvy-in-tre-1ff3f640)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)
- 2026-07-20 13:05 EST — ACAD — [Acadia Pharmaceuticals Receives FDA Fast Track Designation for Remlifanserin in Alzheimer's Disease Psychosis](https://biopharmsignal.com/news/ACAD/acadia-pharmaceuticals-receives-fda-fast-track-designation-for-remlifanserin-in--f36b622c)